400 related articles for article (PubMed ID: 8555556)
1. Hepatitis C virus RNA in patients with anti-HCV on hemodialysis. Relationship to transaminase levels.
Garcia-Valdecasas J; Bernal C; Cerezo S; Garcia F; Montiel N; Leyva A; Umana WO; Bosch JP
ASAIO J; 1994; 40(3):M450-3. PubMed ID: 8555556
[TBL] [Abstract][Full Text] [Related]
2. Quantitative assessment of hepatitis C virus RNA and IgM antibodies to hepatitis C core in chronic hepatitis C.
Martinelli AL; Brown D; Braun HB; Michel G; Dusheiko GM
J Hepatol; 1996 Jan; 24(1):21-6. PubMed ID: 8834020
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus RNA and hepatitis C virus antibody in the serum of patients with abnormal liver function.
Ichimura H; Tamura I; Yamada O; Takezaki E; Koda T; Kurimura O; Kurimura T
J Infect; 1992 Jul; 25(1):47-53. PubMed ID: 1381735
[TBL] [Abstract][Full Text] [Related]
4. Determination of the cut-off value of serum alanine aminotransferase in patients undergoing hemodialysis, to identify biochemical activity in patients with hepatitis C viremia.
Lopes EP; Gouveia EC; Albuquerque AC; Sette LH; Mello LA; Moreira RC; Coelho MR
J Clin Virol; 2006 Mar; 35(3):298-302. PubMed ID: 16290052
[TBL] [Abstract][Full Text] [Related]
5. The fluctuations of hepatitis C virus RNA and IgM anti-HCV (core) serum levels correlate with those of alanine aminotransferases during the hepatitis relapses of patients treated with interferon.
Negro F; Abate ML; Mondardini A; Baldi M; Leandro G; Lombardi S; Wolfe L; Ryff JC; Verme G; Brunetto MR
J Viral Hepat; 1995; 2(4):171-4. PubMed ID: 7489343
[TBL] [Abstract][Full Text] [Related]
6. [Significance of alanine aminotransferase screening in blood donors for risk reduction of hepatitis B and C transmission by haemotherapy].
Kusendová K; Gavorník P; Sabaka P; Sviteková K
Vnitr Lek; 2016 Jan; 62(1):9-16. PubMed ID: 26967232
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus infection-associated markers in sera from blood donors in Surabaya, Indonesia.
Darmadi S; Soetjipto ; Handajani R; Lusida MI; Soemarto ; Sakugawa H; Ishido S; Hotta H
Microbiol Immunol; 1996; 40(5):401-5. PubMed ID: 8805106
[TBL] [Abstract][Full Text] [Related]
8. [Comparison of hepatitis C virus (HCV) RNA and anti-HCV results and evaluation of the relationship between transaminase levels].
Kaşifoğlu N; Us T; Akgün Y
Mikrobiyol Bul; 2007 Oct; 41(4):557-63. PubMed ID: 18173074
[TBL] [Abstract][Full Text] [Related]
9. Markers of hepatitis C virus infection in Sardinian blood donors: relationship with alanine aminotransferase levels.
Lai ME; Mazzoleni AP; Farci P; Melis A; Porru A; Orgiana G; Arnone M; Balestrieri A
J Med Virol; 1993 Dec; 41(4):282-8. PubMed ID: 7508972
[TBL] [Abstract][Full Text] [Related]
10. HCV-RNA and anti-HCV IgM in Egyptian subjects bearing IgG anti-HCV antibodies.
el-Gohary A; Hosny AM; Fawaz N; Heiba A; Abdalla E; Kawano F; Kiyokawa T
Jpn J Infect Dis; 1999 Jun; 52(3):113-6. PubMed ID: 10507990
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus RNA in serum of blood donors with or without elevated transaminase levels.
Romeo R; Thiers V; Driss F; Berthelot P; Nalpas B; Brechot C
Transfusion; 1993 Aug; 33(8):629-33. PubMed ID: 7688157
[TBL] [Abstract][Full Text] [Related]
12. Increasing serum levels of IgM anti-HCV are diagnostic of recurrent hepatitis C in liver transplant patients with ALT flares.
Ciccorossi P; Filipponi F; Oliveri F; Campani D; Colombatto P; Bonino F; Campa M; Maltinti G; Mosca F; Brunetto MR
J Viral Hepat; 2003 May; 10(3):168-73. PubMed ID: 12753334
[TBL] [Abstract][Full Text] [Related]
13. [Investigation of hepatitis B and hepatitis C virus infections by serological and molecular methods in hemodialysis patients].
Dağlar D; Ergani A; Demirbakan H; Ozhak Baysan B; Ongüt G; Koçak H; Oğünç D; Akbaş H; Yıldırım B; Colak D
Mikrobiyol Bul; 2014 Jan; 48(1):143-50. PubMed ID: 24506725
[TBL] [Abstract][Full Text] [Related]
14. Immunoglobulin G and M hepatitis C virus core antibody (JCC.2) response in chimpanzees infected experimentally with hepatitis C virus.
Shioda A; Moriyama M; Hayashi N; Sugitani M; Uchida T; Shikata T; Nishizono A; Abe K; Arakawa Y
Intervirology; 2000; 43(3):146-53. PubMed ID: 11044808
[TBL] [Abstract][Full Text] [Related]
15. Markers of hepatitis C infection among hemodialysis patients with acute and chronic infection: implications for infection control strategies in hemodialysis units.
Oliva JA; Ercilla G; Mallafre JM; Bruguera M; Carrió J; Pereira BJ
Int J Artif Organs; 1995 Feb; 18(2):73-7. PubMed ID: 7558399
[TBL] [Abstract][Full Text] [Related]
16. [Correlation between hepatitis C virus (HVC) RNA and anti-HVC antibodies in a hemodialysis population].
Bouchardeau F; Chauveau P; Le Marrec N; Réach I; Naret C; Girault A; Zamroud M; Zins B; Finetti P; Couroucé AM
Rev Fr Transfus Hemobiol; 1993 Oct; 36(5):451-64. PubMed ID: 7505079
[TBL] [Abstract][Full Text] [Related]
17. [The diagnostic significance of anti-HCV IgM in chronic hepatitis C viral infection].
Wu H; Wang J; Lin X
Zhonghua Nei Ke Za Zhi; 1995 Jan; 34(1):42-5. PubMed ID: 7541329
[TBL] [Abstract][Full Text] [Related]
18. Significance of anti-hepatitis C virus core IgM antibodies in patients with chronic hepatitis C.
Pawlotsky JM; Darthuy F; Rémiré J; Pellet C; Udin L; Stuyver L; Roudot-Thoraval F; Duvoux C; Douvin C; Mallat A
J Med Virol; 1995 Nov; 47(3):285-91. PubMed ID: 8551282
[TBL] [Abstract][Full Text] [Related]
19. Correlation of plasma hepatitis C virus RNA levels with serum alanine aminotransferase in non-A, non-B chronic liver disease.
Kurosaki M; Enomoto N; Sato C; Sakamoto N; Hoshino Y; Haritani H; Marumo F
J Med Virol; 1993 Mar; 39(3):246-50. PubMed ID: 7682256
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus-RNA, immunoglobulin M anti-HCV and risk factors in haemodialysis patients.
Dentico P; Sacco R; Buongiorno R; Volpe A; Ranieri C; Carbone M; Carabellese S
Microbios; 1999; 99(392):55-62. PubMed ID: 10624011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
